Aclaris Therapeutics, Inc(NASDAQ:ACRS) 
Aclaris Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing drug candidates for immuno-inflammatory diseases in the United States. The Company operates in two segments, Therapeutics and Contract Research. Its products pipeline includes ATI-450, an investigational or...
Website: http://www.aclaristx.com
Founded: 2012
Full Time Employees: 75
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.46
H 1.46
L 1.34
C 1.40
V 812,283
10EMA 1.40
20EMA 1.40
60EMA 1.40
120EMA 1.40
250EMA 1.40